More life sciences companies are bringing together their QMS and
content management systems on a single cloud platform to drive greater
efficiency and visibility across quality processes
PHILADELPHIA--(BUSINESS WIRE)--
Veeva
Systems (NYSE:VEEV) announced that Veeva
Vault Quality is helping an increasing number of life sciences
customers to modernize quality and content management in the cloud. The
number of Vault Quality customers has increased to 120, including four
of the top 20 largest biopharmaceutical companies and 30 Veeva Vault QMS
customers. More life sciences companies are using Vault Quality
applications to support their end-to-end processes across internal and
external stakeholders for greater visibility and control.
“We wanted our quality system accessible to suppliers beyond our four
walls so we could improve quality in the supply chain,” said James
Huang, director of global quality systems at Atrium Innovations. “Vault
Quality enables us to bring parties together to manage change control
more effectively, improve collaboration to solve quality problems, and
harmonize different business processes to speed workflows.”
The continued outsourcing of critical manufacturing functions and the
high costs of quality issues are prompting companies to improve quality
management. Many organizations are moving away from manual processes and
system silos to streamline processes across global sites, suppliers,
contract manufacturers, and other partners.
Veeva
Vault QMS and Veeva
Vault QualityDocs are part of Vault Quality, the industry’s first
and only unified suite of quality applications for seamless end-to-end
quality and content management. Companies are adopting Vault QMS and
Vault QualityDocs to standardize the flow of information while ensuring
process transparency.
“A major transformation in the life sciences industry is underway to
modernize quality applications and processes,” said Mike Jovanis, vice
president of Vault Quality at Veeva. “Veeva Vault Quality is replacing
disparate legacy systems and making it easier to bring internal and
external stakeholders into quality processes with cloud applications
that are much easier to use.”
In other news today, Veeva announced that the adoption of Veeva
Vault CTMS is gaining momentum with customers needing to unify
clinical information and processes across their studies. Read our press
release to learn more.
Veeva also announced today its intention to enter the safety market with
Veeva Vault Safety. Veeva will develop cloud applications that help
pharmacovigilance and safety departments increase efficiency and
maintain compliance in managing safety processes. The addition of Vault
Safety with Vault
Clinical, Vault
Quality, and Vault
RIM will make Vault Development Cloud the most comprehensive suite
of unified cloud applications to help life sciences companies speed drug
development. Vault Safety is expected to be available in 2019.
Additional Information
For more on Veeva Vault Quality, visit: veeva.com/VaultQuality
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 550 customers, including 280+
Veeva CRM customers, 160+ Vault Clinical customers, 120+ Vault Quality
customers, and 110+ Vault Regulatory customers. Veeva customers range
from emerging biotechs to the world’s top 20 largest biopharmaceutical
companies that are deploying Veeva solutions globally, including Veeva
CRM (19 of top 20), Vault Clinical (eight of top 20), Vault Quality
(four of top 20), and Vault Regulatory (four of top 20). Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2017. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171003005652/en/
Source: Veeva Systems